USE OF ESTROGEN RECEPTOR-beta; SELECTIVE AGONISTS FOR RADIATION-OR CHEMOTHERAPY-INDUCED MUCOSITIS AND RADIATION CYSTITIS

摘要

The present invention provides a method of treating or inhibiting mucositis or radiation cystitis using an ERF selective ligand. The present invention also provides compositions, including pharmaceutical compositions, containing the ERF selective ligand and a traditional medicament for mucositis or radiation cystitis.